BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22980431)

  • 21. Prevention of postpartum hemorrhage: options for home births in rural Ethiopia.
    Prata N; Gessessew A; Abraha AK; Holston M; Potts M
    Afr J Reprod Health; 2009 Jun; 13(2):87-95. PubMed ID: 20690252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postpartum hemorrhage today: ICM/FIGO initiative 2004-2006.
    Lalonde A; Daviss BA; Acosta A; Herschderfer K
    Int J Gynaecol Obstet; 2006 Sep; 94(3):243-53. PubMed ID: 16842791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New global guidance supports community and lay health workers in postpartum hemorrhage prevention.
    Ejembi CL; Norick P; Starrs A; Thapa K
    Int J Gynaecol Obstet; 2013 Sep; 122(3):187-9. PubMed ID: 23796260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community-based distribution of misoprostol for treatment or prevention of postpartum hemorrhage: cost-effectiveness, mortality, and morbidity reduction analysis.
    Sutherland T; Meyer C; Bishai DM; Geller S; Miller S
    Int J Gynaecol Obstet; 2010 Mar; 108(3):289-94. PubMed ID: 20079493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of sublingual misoprostol as first-line treatment for primary post-partum hemorrhage: results of a multicenter trial.
    Okonofua FE; Ogu RN; Akuse JT; Ujah IA; Galadanci HS; Fabamwo AO
    J Obstet Gynaecol Res; 2014 Mar; 40(3):718-22. PubMed ID: 24320203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date.
    Smith JM; Gubin R; Holston MM; Fullerton J; Prata N
    BMC Pregnancy Childbirth; 2013 Feb; 13():44. PubMed ID: 23421792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Misoprostol in preventing postpartum hemorrhage: a meta-analysis.
    Langenbach C
    Int J Gynaecol Obstet; 2006 Jan; 92(1):10-8. PubMed ID: 16309682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage.
    Nasr A; Shahin AY; Elsamman AM; Zakherah MS; Shaaban OM
    Int J Gynaecol Obstet; 2009 Jun; 105(3):244-7. PubMed ID: 19249048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Misoprostol in the prevention of postpartum hemorrhage.
    Mategrano VA; Gabay MP
    Ann Pharmacother; 2001 Dec; 35(12):1648-52. PubMed ID: 11793636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction of misoprostol for prevention of postpartum hemorrhage at the community level in Senegal.
    Diadhiou M; Dieng T; Ortiz C; Mall I; Dione D; Sloan NL
    Int J Gynaecol Obstet; 2011 Dec; 115(3):251-5. PubMed ID: 21982859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scaling up interventions: findings and lessons learned from an external evaluation of Niger's National Initiative to reduce postpartum hemorrhage.
    Mary M; Diop A; Sheldon WR; Yenikoye A; Winikoff B
    BMC Pregnancy Childbirth; 2019 Oct; 19(1):379. PubMed ID: 31651264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India.
    Chandhiok N; Dhillon BS; Datey S; Mathur A; Saxena NC
    Int J Gynaecol Obstet; 2006 Feb; 92(2):170-5. PubMed ID: 16371228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Healthcare providers' knowledge and practices associated with postpartum hemorrhage during facility delivery in Dar es Salaam, Tanzania.
    Carnahan LR; Geller SE; Leshabari S; Sangu W; Hanselman B; Patil CL
    Int J Gynaecol Obstet; 2016 Dec; 135(3):268-271. PubMed ID: 27569024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scaling Up Misoprostol to Prevent Postpartum Hemorrhage at Home Births in Mozambique: A Case Study Applying the ExpandNet/WHO Framework.
    Hobday K; Hulme J; Prata N; Wate PZ; Belton S; Homer C
    Glob Health Sci Pract; 2019 Mar; 7(1):66-86. PubMed ID: 30926738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Misoprostol for postpartum hemorrhage: moving from evidence to practice.
    Starrs A; Winikoff B
    Int J Gynaecol Obstet; 2012 Jan; 116(1):1-3. PubMed ID: 22078140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postpartum hemorrhage prevention in Nepal: a program assessment.
    Rajbhandari SP; Aryal K; Sheldon WR; Ban B; Upreti SR; Regmi K; Aryal S; Winikoff B
    BMC Pregnancy Childbirth; 2017 Jun; 17(1):169. PubMed ID: 28583092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of postpartum hemorrhage with misoprostol.
    Alfirevic Z; Blum J; Walraven G; Weeks A; Winikoff B
    Int J Gynaecol Obstet; 2007 Dec; 99 Suppl 2():S198-201. PubMed ID: 17961574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A regional comparison of distribution strategies and women's awareness, receipt, and use of misoprostol to prevent postpartum hemorrhage in rural Amhara and Oromiya regions of Ethiopia.
    Sibley LM; Spangler SA; Barry D; Tesfaye S; Desta BF; Gobezayehu AG
    J Midwifery Womens Health; 2014 Jan; 59 Suppl 1():S73-82. PubMed ID: 24588919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial.
    Derman RJ; Kodkany BS; Goudar SS; Geller SE; Naik VA; Bellad MB; Patted SS; Patel A; Edlavitch SA; Hartwell T; Chakraborty H; Moss N
    Lancet; 2006 Oct; 368(9543):1248-53. PubMed ID: 17027730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health.
    Sheldon WR; Blum J; Vogel JP; Souza JP; Gülmezoglu AM; Winikoff B;
    BJOG; 2014 Mar; 121 Suppl 1():5-13. PubMed ID: 24641530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.